Concepedia

Linda Bao

LB

Statistics

Publications

6

Citations

349

H-Index

6

Active since

2011

Affiliations

Paraza Pharma (Canada)(Current)

Linda Bao is an author at Paraza Pharma (Canada) specializing in drug discovery, pharmacology, and hit-to-lead optimization.

Publications per year

2011–2024

6

Publications

6

Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer

Daniel P. Sutherlin, Linda Bao, Megan Berry et al. · Journal of Medicinal Chemistry · 2011 · 217 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Discovery and Biological Profiling of Potent and Selective mTOR Inhibitor GDC-0349

Zhonghua Pei, Elizabeth Blackwood, Lichuan Liu et al. · ACS Medicinal Chemistry Letters · 2012 · 46 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

In Vitro and In Vivo Evaluation of Amorphous Solid Dispersions Generated by Different Bench-Scale Processes, Using Griseofulvin as a Model Compound

Po‐Chang Chiang, Yong Cui, Yingqing Ran et al. · The AAPS Journal · 2013 · 33 citations

Pharmacy, Materials Science, Pharmaceutics +9

Discovery of TRPA1 Antagonist <b>GDC-6599</b>: Derisking Preclinical Toxicity and Aldehyde Oxidase Metabolism with a Potential First-in-Class Therapy for Respiratory Disease

Jack A. Terrett, Justin Q. Ly, Paula Katavolos et al. · Journal of Medicinal Chemistry · 2024 · 21 citations · Full text

Medicine, Neuroscience, Pharmacology +17

On Demand Bioorthogonal Switching of an Antibody-Conjugated SPECT Probe to a Cytotoxic Payload: from Imaging to Therapy

Pragya Adhikari, Guangmin Li, MaryAnn Go et al. · Journal of the American Chemical Society · 2024 · 18 citations

Pharmacy, Pharmaceutics, Pharmacology +17

1–5 of 6